Skip to content
Screener

Revvity RVTY Goodwill, Acquisition

Segments

By segment

See full
Life Sciences$32.04M—
Diagnostics$0—

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%—
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept revv:GoodwillAcquisition.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemLife SciencesDiagnosticsConsolidated
Balance at December 28, 2025$4,744,962$1,868,531$6,613,493
Foreign currency translation(24,952)(9,826)(34,778)
Acquisitions32,035—32,035
Balance at April 5, 2026$4,752,045$1,858,705$6,610,750

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's goodwill, acquisition?
Revvity (RVTY) reported goodwill, acquisition of $32.04M in Q1 2026.

Ask your AI about Revvity's goodwill, acquisition.

Connect your AI assistant and break it down by segment, right in your chat.

Connect your AI
Harbor at dusk
Claude